Episode Player

Scientists from Duke-NUS and the National Centre for Infectious Diseases (NCID) found that 2003 SARS survivors who have been vaccinated with the Pfizer-BioNTech mRNA vaccine produced highly potent functional antibodies that are capable of neutralising not only all known SARS-CoV-2.

To discover more scientific insights and personal stories from Singapore with impact on the world, go to: www.duke-nus.edu.sg/medicus